AuthorsShalet, Stephen M
AffiliationChristie Hospital NHS Trust, Manchester, UK. firstname.lastname@example.org
MetadataShow full item record
AbstractThe period of growth from late puberty to full adult maturation, termed the transition period, is important for tissue maturation. Peak bone mass, muscle mass and strength are usually attained in this period. However, it is common clinical practice in children with growth hormone deficiency (GHD) to discontinue growth hormone (GH) treatment in adolescence after attainment of final height. Therefore, patients with childhood-onset GHD that continues into adulthood and who do not receive treatment as adults may experience more severe consequences than patients who acquire GHD as an adult. Recent studies indicate that bone and muscle maturation are attenuated if GH treatment is discontinued at final height. Furthermore, these patients will also develop cardiovascular risk factors that are normally associated with GHD in adults. Much debate surrounds when retesting for GHD should be carried out and when GH treatment should be restarted in adolescents; many of these patients will not have severe GHD according to the criteria set for adults. The transition period is an appropriate time to modify GH doses. Finally, registries exist that have recorded clinical treatment experiences for children and adults. Tools that collect and analyse data provide an important opportunity to investigate issues related to transition.
CitationStepping into adulthood: the transition period. 2004, 62 Suppl 4:15-22 Horm. Res.
- Growth hormone deficiency: strategies and indications to continue growth hormone therapy in transition from adolescence to adult life.
- Authors: Leong GM, Johannsson G
- Issue date: 2003
- Acquisition of bone mass in normal individuals and in patients with growth hormone deficiency.
- Authors: Baroncelli GI, Bertelloni S, Sodini F, Saggese G
- Issue date: 2003 Mar
- Long-term challenges in growth hormone treatment.
- Authors: Leal Cerro A
- Issue date: 2004
- Reassessment of growth hormone status is required at final height in children treated with growth hormone replacement after radiation therapy.
- Authors: Gleeson HK, Gattamaneni HR, Smethurst L, Brennan BM, Shalet SM
- Issue date: 2004 Feb
- Advances in growth hormone therapy: a new registry tool.
- Authors: Pugeat M
- Issue date: 2004